PTCT

PTC Therapeutics, Inc.

28.69 USD
+0.49 (+1.74%)
Last updated
This page is just a preview of the data found in TrendSpider’s full version

PTC Therapeutics, Inc. stock is up 8.02% since 30 days ago. The next earnings date is Feb 29, 2024. The company has had below-average volume in the last 30 days. Its seasonality going into this month shows a chance of a green month, as 54.55% of the previous 10 February’s closed higher than January. In the last 6 Unusual Options Trades, there were 2 CALLs, 4 PUTs.

Options Flow Last 10
Date & Time Expiration Date Strike Price Trade Type Size Open Interest
22 Jan 16:00 16 Feb, 2024 29.00 CALL 127 104
22 Jan 19:00 15 Mar, 2024 25.00 PUT 80 618
24 Jan 20:06 19 Apr, 2024 31.00 PUT 100 0
26 Jan 15:35 15 Mar, 2024 28.00 PUT 73 13
13 Feb 17:12 19 Apr, 2024 20.00 PUT 4999 9
14 Feb 20:32 19 Apr, 2024 31.00 CALL 797 2

About PTC Therapeutics, Inc.

PTC Therapeutics focuses on the discovery, development, and commercialization of medicines to patients with rare disorders. The company offers Translarna and Emflaza for the treatment of Duchenne muscular dystrophy in the European Economic Area and the United States; Tegsedi and Waylivra for the. treatment of rare diseases in Latin America and the Caribbean. PTC518 is being developed for Huntington's disease.